[H931-1am] 17. Biofunctional Chemistry, Biotechnology

10:50 AM - 11:00 AM JST(1:50 AM - 2:00 AM UTC)Japanese

[H931-1am-11] Cancer Treatment through [3+2] Cycloaddition Reaction with Patient-Derived Cancer Metabolites in Mouse Models

○Yuria Takahashi¹, Kazuki Terashima¹, Ambara Rachmat Pradipta¹, Katsunori Tanaka^1,2 (1. Tokyo Institute of Technology, School of Materials and Chemical Technology, Department of Chemical Science and Engineering, 2. RIKEN Cluster for Pioneering Research, Biofunctional Synthetic Chemistry Laboratory)

Keywords:

Cancer therapy,Prodrug,Acrolein,[3+2] cycloaddition reaction,In vivo synthesis